Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association of HIV Status With Outcomes of Anal Squamous Cell Carcinoma in the Era of Highly Active Antiretroviral Therapy.

× No keyword cloud information.

6 in total

1. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?

Authors: Ingeborg Fraunholz; Daniela Rabeneck; Johanna Gerstein; Katharina Jäck; Annette Haberl; Christian Weiss; Claus Rödel
Journal: Radiother Oncol Date: 2010-12-17 Impact factor: 6.280

2. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.

Authors: J H Kim; B Sarani; B A Orkin; H A Young; J White; I Tannebaum; S Stein; B Bennett
Journal: Dis Colon Rectum Date: 2001-10 Impact factor: 4.585

3. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.

Authors: R J Place; S G Gregorcyk; P J Huber; C L Simmang
Journal: Dis Colon Rectum Date: 2001-04 Impact factor: 4.585

4. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.

Authors: Elizabeth Y Chiao; Thomas P Giordano; Peter Richardson; Hashem B El-Serag
Journal: J Clin Oncol Date: 2008-01-20 Impact factor: 44.544

5. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.

Authors: Yuji Seo; Michael T Kinsella; Harry L Reynolds; Gregory Chipman; Scot C Remick; Timothy J Kinsella
Journal: Int J Radiat Oncol Biol Phys Date: 2009-02-07 Impact factor: 7.038

6. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.

Authors: Christoph Oehler-Jänne; Florence Huguet; Sawyna Provencher; Burkhardt Seifert; Laura Negretti; Marc-Oliver Riener; Marta Bonet; Abdelkarim S Allal; I Frank Ciernik
Journal: J Clin Oncol Date: 2008-04-21 Impact factor: 44.544

6 in total

8 in total

1. Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era.

Authors: Keri L Calkins; Geetanjali Chander; Corinne E Joshu; Kala Visvanathan; Anthony T Fojo; Catherine R Lesko; Richard D Moore; Bryan Lau
Journal: JAMA Oncol Date: 2020-02-01 Impact factor: 31.777

Review 2. HIV-Associated Anal Cancer.

Authors: Pushti Khandwala; Sachi Singhal; Devashish Desai; Meghana Parsi; Rashmika Potdar
Journal: Cureus Date: 2021-05-04

Association of HIV Status With Outcomes of Anal Squamous Cell Carcinoma in the Era of Highly Active Antiretroviral Therapy.

1. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?

2. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.

3. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.

4. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.

5. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.

6. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.

1. Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era.

Review 2. HIV-Associated Anal Cancer.

Review 3. The effect of non-AIDS-defining cancers on people living with HIV.

4. Does HIV undermine breast cancer outcomes in women?

Review 5. A Review of Chronic Comorbidities in Adults Living With HIV: State of the Science.

6. Socioeconomic disparities in timeliness of care and outcomes for anal cancer patients.

Review 7. Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment.

8. Patterns of HIV Self-Disclosure in the Oncology Setting.